{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:24:52Z","timestamp":1792610692235,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["RGP1\/113\/45"],"award-info":[{"award-number":["RGP1\/113\/45"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bioorg.2025.108159","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T11:29:04Z","timestamp":1736594944000},"page":"108159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Design and synthesis of new 1,2,3-triazole derivatives as VEGFR-2\/telomerase downregulatory candidates endowed with apoptotic potential for cancer treatment"],"prefix":"10.1016","volume":"156","author":[{"given":"Ahmed A.","family":"Al-Karmalawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Zeidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman Abo","family":"Elmaaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Sharaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa S.A.","family":"Yassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman F.","family":"Khaleel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagdy M.","family":"Eldehna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba F.","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108159_b0005","article-title":"Cancer scenario in India with future perspectives","volume":"8","author":"Ali","year":"2011","journal-title":"Cancer Therapy"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108159_b0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12885-024-11986-4","article-title":"5-Methoxytryptophan enhances the sensitivity of sorafenib on the inhibition of proliferation and metastasis for lung cancer cells","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108159_b0015","first-page":"70","article-title":"The side effects of chemotherapeutic agents","volume":"19","author":"Carr","year":"2008","journal-title":"Curr. Anaesth. Crit. Care"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108159_b0020","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12672-024-01195-7","article-title":"Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy","volume":"15","author":"Joshi","year":"2024","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108159_b0025","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2022.2157825","article-title":"Design and synthesis of novel rigid dibenzo[b,f]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators","volume":"38","author":"El-Behairy","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108159_b0030","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.93902","article-title":"Location, location, location: Protein kinase nanoclustering for optimised signalling output","volume":"13","author":"Gormal","year":"2024","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108159_b0035","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/jcb.21707","article-title":"Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities","volume":"104","author":"Plati","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2025.108159_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103422","article-title":"Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4 (3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"94","author":"Mahdy","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108159_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2005-6-2-209","article-title":"The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease","volume":"6","author":"Holmes","year":"2005","journal-title":"Genome Biol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108159_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22228","article-title":"Exploring chromone-2-carboxamide derivatives for triple-negative breast cancer targeting EGFR, FGFR3, and VEGF pathways: Design, synthesis, and preclinical insights","volume":"85","author":"El-Gamil","year":"2024","journal-title":"Drug Dev. Res."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108159_b0055","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","article-title":"Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition","volume":"19","author":"Holmes","year":"2007","journal-title":"Cell. Signal."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108159_b0060","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1016\/j.ejmech.2010.09.002","article-title":"Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors","volume":"45","author":"Lee","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2025.108159_b0065","first-page":"12184","article-title":"Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, and in silico studies, RSC","volume":"13","author":"Al-Muntaser","year":"2023","journal-title":"Advances"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108159_b0070","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/ph15040481","article-title":"New Genetic Bomb Trigger: Design, Synthesis, Molecular Dynamics Simulation, and Biological Evaluation of Novel BIBR1532-Related Analogs Targeting Telomerase against Non-Small Cell Lung Cancer","volume":"15","author":"Tawfik","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"19","key":"10.1016\/j.bioorg.2025.108159_b0075","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1016\/j.bmcl.2017.08.044","article-title":"Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents","volume":"27","author":"Lv","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2\u20136","key":"10.1016\/j.bioorg.2025.108159_b0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0921-8734(91)90018-7","article-title":"Telomere loss: mitotic clock or genetic time bomb?","volume":"256","author":"Harley","year":"1991","journal-title":"Mutation Research\/DNAging"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108159_b0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrc2275","article-title":"Telomerase and cancer therapeutics","volume":"8","author":"Harley","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108159_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17133-4","article-title":"Persistent telomere cohesion protects aged cells from premature senescence","volume":"11","author":"Azarm","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108159_b0095","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nrurol.2017.104","article-title":"Telomeres and telomerase in prostate cancer development and therapy","volume":"14","author":"Graham","year":"2017","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108159_b0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/antiox6010015","article-title":"Treating cancer by targeting telomeres and telomerase","volume":"6","author":"Ivancich","year":"2017","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108159_b0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/genes7060022","article-title":"Telomere and telomerase therapeutics in cancer","volume":"7","author":"Xu","year":"2016","journal-title":"Genes"},{"issue":"36","key":"10.1016\/j.bioorg.2025.108159_b0110","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.1038\/s41388-020-01405-w","article-title":"Targeting telomerase for cancer therapy","volume":"39","author":"Guterres","year":"2020","journal-title":"Oncogene"},{"issue":"75","key":"10.1016\/j.bioorg.2025.108159_b0115","doi-asserted-by":"crossref","first-page":"47297","DOI":"10.1039\/C7RA07257K","article-title":"Development of a series of bis-triazoles as G-quadruplex ligands","volume":"7","author":"Saleh","year":"2017","journal-title":"RSC Adv."},{"issue":"42","key":"10.1016\/j.bioorg.2025.108159_b0120","doi-asserted-by":"crossref","first-page":"36945","DOI":"10.1021\/acsomega.2c04883","article-title":"Versatile synthetic platform for 1, 2, 3-triazole chemistry","volume":"7","author":"Vala","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.108159_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112085","article-title":"Design, synthesis and structure-activity relationships of 4-phenyl-1H-1, 2, 3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities","volume":"190","author":"Sun","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108159_b0130","doi-asserted-by":"crossref","unstructured":"D. Gonzaga, M.R. Senger, F.d.C. Da Silva, V.F. Ferreira, F.P. Silva-Jr, 1-Phenyl-1H-and 2-phenyl-2H-1, 2, 3-triazol derivatives: Design, synthesis and inhibitory effect on alpha-glycosidases, European Journal of Medicinal Chemistry 74 (2014) 461-476.","DOI":"10.1016\/j.ejmech.2013.12.039"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108159_b0135","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3390\/molecules23061344","article-title":"Design, synthesis, and antifungal activity of novel aryl-1, 2, 3-triazole-\u03b2-carboline hybrids","volume":"23","author":"Huo","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108159_b0140","doi-asserted-by":"crossref","unstructured":"K.N. Venugopala, G. Dharma Rao, S. Bhandary, M. Pillay, D. Chopra, B.E. Aldhubiab, M. Attimarad, O.I. Alwassil, S. Harsha, K. Mlisana, Design, synthesis, and characterization of (1-(4-aryl)-1 H-1, 2, 3-triazol-4-yl) methyl, substituted phenyl-6-methyl-2-oxo-1, 2, 3, 4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis, Drug design, development and therapy (2016) 2681-2690.","DOI":"10.2147\/DDDT.S109760"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108159_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300673","article-title":"Indole clubbed 2, 4\u2010thiazolidinedione linked 1, 2, 3\u2010triazole as a potent antimalarial and antibacterial agent against drug\u2010resistant strain and molecular modeling studies","volume":"357","author":"Upadhyay","year":"2024","journal-title":"Arch. Pharm."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108159_b0150","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1016\/j.bmcl.2017.06.059","article-title":"Synthesis and evaluation of 1-phenyl-1H-1, 2, 3-triazole-4-carboxylic acid derivatives as xanthine oxidase inhibitors","volume":"27","author":"Zhang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"115","key":"10.1016\/j.bioorg.2025.108159_b0155","doi-asserted-by":"crossref","first-page":"114879","DOI":"10.1039\/C6RA24651F","article-title":"Synthesis and bioevaluation of 2-phenyl-5-methyl-2 H-1, 2, 3-triazole-4-carboxylic acid\/carbohydrazide derivatives as potent xanthine oxidase inhibitors","volume":"6","author":"Shi","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.108159_b0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2017.04.040","article-title":"Design, combinatorial synthesis and biological evaluations of novel 3-amino-1\u2032-((1-aryl-1H-1, 2, 3-triazol-5-yl) methyl)-2\u2032-oxospiro [benzo [a] pyrano [2, 3-c] phenazine-1, 3\u2032-indoline]-2-carbonitrile antitumor hybrid molecules","volume":"135","author":"Lu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108159_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112813","article-title":"Design, synthesis and comparative analysis of triphenyl-1, 2, 3-triazoles as anti-proliferative agents","volume":"207","author":"Dheer","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108159_b0170","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1080\/10406638.2022.2137205","article-title":"Design and click synthesis of novel 1-substituted-4-(3, 4-dimethoxyphenyl)-1 H-1, 2, 3-triazole hybrids for anticancer evaluation and molecular docking","volume":"43","author":"El Malah","year":"2023","journal-title":"Polycycl. Aromat. Compd."},{"key":"10.1016\/j.bioorg.2025.108159_b0175","article-title":"Click-chemistry mediated synthesis of OTBN-1, 2, 3-Triazole derivatives exhibiting STK33 inhibition with diverse anti-cancer activities","volume":"107485","author":"Vala","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108159_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113083","article-title":"Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1, 2, 3-triazole scaffold","volume":"211","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108159_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135165","article-title":"Design, synthesis, and antiproliferative properties of new 1, 2, 3-triazole-carboximidamide derivatives as dual EGFR\/VEGFR-2 inhibitors","volume":"1282","author":"Mahmoud","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108159_b0190","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2305856","article-title":"Design, synthesis, and apoptotic antiproliferative action of new 1, 2, 3-triazole\/1, 2, 4-oxadiazole hybrids as dual EGFR\/VEGFR-2 inhibitors","volume":"39","author":"Mahmoud","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108159_b0195","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300320","article-title":"Identification of novel sulfathiazole-triazolo-chalcone hybrids as VEGFR-2\/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction","volume":"357","author":"Zeidan","year":"2024","journal-title":"Arch. Pharm."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108159_b0200","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1021\/acs.jmedchem.0c00636","article-title":"Azidothymidine \u201cClicked\u201d into 1, 2, 3-triazoles: first report on carbonic anhydrase\u2013telomerase dual-hybrid inhibitors","volume":"63","author":"Berrino","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108159_b0205","doi-asserted-by":"crossref","unstructured":"J. Mahesh Kumar, M.M. Idris, G. Srinivas, P. Vinay Kumar, V. Meghah, M. Kavitha, C.R. Reddy, P.S. Mainkar, B. Pal, S. Chandrasekar, Phenyl 1, 2, 3-triazole-thymidine ligands stabilize G-quadruplex DNA, inhibit DNA synthesis and potentially reduce tumor cell proliferation over 3\u2032-azido deoxythymidine, PLoS One 8(8) (2013) e70798.","DOI":"10.1371\/journal.pone.0070798"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108159_b0210","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1039\/D0MD00414F","article-title":"Benzimidazole-1, 2, 3-triazole hybrid molecules: synthesis and study of their interaction with G-quadruplex DNA","volume":"12","author":"Singu","year":"2021","journal-title":"RSC Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108159_b0215","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.drudis.2020.07.004","article-title":"Recent advances in multitarget-directed ligands targeting G-protein-coupled receptors","volume":"25","author":"Ma","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108159_b0220","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.3390\/ijms21103483","article-title":"Overview of dual-acting drug methotrexate in different neurological diseases, autoimmune pathologies and cancers","volume":"21","author":"Ko\u017ami\u0144ski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108159_b0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nurt.2008.10.039","article-title":"Dual-and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs","volume":"6","author":"Millan","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bioorg.2025.108159_b0230","doi-asserted-by":"crossref","unstructured":"M.A. Mourad, A. Abo Elmaaty, I. Zaki, A.A. Mourad, A. Hofni, A.E. Khodir, E.M. Aboubakr, A. Elkamhawy, E.J. Roh, A.A. Al-Karmalawy, Novel topoisomerase II\/EGFR dual inhibitors: design, synthesis and docking studies of naphtho [2\u2032, 3\u2032: 4, 5] thiazolo [3, 2-a] pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity, Journal of Enzyme Inhibition and Medicinal Chemistry 38(1) (2023) 2205043.","DOI":"10.1080\/14756366.2023.2205043"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108159_b0235","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1517\/14656560902781907","article-title":"Multitarget drugs: the present and the future of cancer therapy","volume":"10","author":"Petrelli","year":"2009","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108159_b0240","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jmgm.2008.11.008","article-title":"Pharmacophore modeling studies of type I and type II kinase inhibitors of Tie2","volume":"27","author":"Xie","year":"2009","journal-title":"J. Mol. Graph. Model."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108159_b0245","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2013.11.029","article-title":"Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma\u2014mechanistics, review of phase III randomized clinical trials, and regulatory implications","volume":"132","author":"Eskander","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bioorg.2025.108159_b0250","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejmech.2019.02.050","article-title":"Design, synthesis and docking study of novel picolinamide derivatives as anticancer agents and VEGFR-2 inhibitors","volume":"168","author":"Zeidan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108159_b0255","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1021\/acs.jmedchem.2c01668","article-title":"Ligand-based design on the dog-bone-shaped BIBR1532 pharmacophoric features and synthesis of novel analogues as promising telomerase inhibitors with in vitro and in vivo evaluations","volume":"66","author":"Al-Karmalawy","year":"2022","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108159_b0260","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"10.1016\/j.bioorg.2025.108159_b0265","article-title":"Discovery of novel quinolin-2-one derivatives as potential GSK-3\u03b2 inhibitors for treatment of Alzheimer\u2019s disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation","volume":"146","author":"Moustafa","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108159_b0270","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108159_b0275","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108159_b0280","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1039\/C0CC02472D","article-title":"Synthesis of phosphonamidate peptides by Staudinger reactions of silylated phosphinic acids and esters","volume":"47","author":"Wilkening","year":"2011","journal-title":"Chem. Commun."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108159_b0285","doi-asserted-by":"crossref","first-page":"o2416","DOI":"10.1107\/S1600536811033940","article-title":"Ethyl 5-methyl-1-(4-nitrophenyl)-1H-1, 2, 3-triazole-4-carboxylate","volume":"67","author":"Fun","year":"2011","journal-title":"Acta Crystallogr. Sect. E: Struct. Rep. Online"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108159_b0290","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.crci.2013.05.006","article-title":"Efficient TMG catalyzed synthesis of 1, 2, 3-triazoles","volume":"16","author":"Ahmadi","year":"2013","journal-title":"C. R. Chim."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108159_b0295","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1039\/c1ob05176h","article-title":"A combined experimental and theoretical study of the thermal cycloaddition of aryl azides with activated alkenes","volume":"9","author":"Zeghada","year":"2011","journal-title":"Org. Biomol. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108159_b0300","first-page":"374","article-title":"Synthesis, characterization and biological studies of 2, 5-substituted 1, 3, 4-thiadiazole carrying 1, 2, 3-triazole core","volume":"6","author":"Kadoor","year":"2014","journal-title":"J. Chem. Pharm. Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108159_b0305","first-page":"207","article-title":"Microwave-assisted Synthesis of 1, 2, 3-Triazole Hydrazone Library and Evaluation of Antibacterial and Antioxidant Activity","volume":"28","author":"Turukarabettu","year":"2018","journal-title":"Indian J. Heterocycl. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108159_b0310","first-page":"81","article-title":"Synthesis and characterization of some new 1, 2, 4-triazines containing 1, 2, 3-triazole","volume":"22","author":"Wang","year":"2012","journal-title":"Indian J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2025.108159_b0315","doi-asserted-by":"crossref","unstructured":"B. Abdel-Wahab, H. Mohaned, E. Awad Gh, Synthesis of 5-(1, 2, 3-triazol-4-yl)-1, 3, 4-oxa (thia) diazol-2-amines as antimicrobial agents, Egypt, J. Chem 57(4) (2014) 257-266.","DOI":"10.21608\/ejchem.2014.1044"},{"key":"10.1016\/j.bioorg.2025.108159_b0320","article-title":"Discovery studio","author":"Studio","year":"2008","journal-title":"Accelrys [2.1]"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108159_b0325","first-page":"e1298","article-title":"Using PyMOL as a platform for computational drug design","volume":"7","author":"Yuan","year":"2017","journal-title":"Wiley Interdiscip. Rev.: Comput. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108159_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2022.2082533","article-title":"Synthesis, structural characterization, DFT calculations, molecular docking, and molecular dynamics simulations of a novel ferrocene derivative to unravel its potential antitumor activity","author":"Hammoud","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108159_b0335","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1039\/D1NJ04816C","article-title":"Newly synthesized series of oxoindole\u2013oxadiazole conjugates as potential anti-SARS-CoV-2 agents: in silico and in vitro studies","volume":"46","author":"El-Masry","year":"2022","journal-title":"New J. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108159_b0340","doi-asserted-by":"crossref","first-page":"12920","DOI":"10.1038\/s41598-022-17082-6","article-title":"Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies","volume":"12","author":"Kutkat","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108159_b0345","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1080\/14756366.2022.2105322","article-title":"Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease","volume":"37","author":"Elagawany","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108159_b0350","unstructured":"A.A. Gaber, A.M. El-Morsy, F.F. Sherbiny, A.H. Bayoumi, K.M. El-Gamal, K. El-Adl, A.A. Al-Karmalawy, R.R. Ezz Eldin, M.A. Saleh, H.S. Abulkhair, Pharmacophore-linked pyrazolo[3,4-d]pyrimidines as EGFR-TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies, Archiv der Pharmazie n\/a(n\/a) e2100258."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108159_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T01:50:37Z","timestamp":1758851437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825000392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":71,"alternative-id":["S0045206825000392"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108159","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of new 1,2,3-triazole derivatives as VEGFR-2\/telomerase downregulatory candidates endowed with apoptotic potential for cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108159"}}